Pharmaceuticals and Biotechnology

Understanding the global landscape and supply of the pharmaceutical and biotechnology industry is a key focus for the CRYOPDP group. Our 25+ years of experience has allowed us to develop unrivalled knowledge and expertise in the global shipping of Active Pharmaceutical Ingredients (APIs), rare and orphan disease drugs, ATMP and cell and gene moves, critical biosimilars and various other therapeutic development and commercial drug moves.  

CRYOPDP has developed a deep understanding of the sensitivities surrounding the distribution process for these types of shipments and strives towards successfully minimizing the risks associated with the various stages involved.

Our global teams focus on the goals that we know are important to our client partners across the Pharmaceutical and Biotechnology industries, which include but are not limited to operational excellence, customer service, cost containment, regulation consultancy and superior cold temperature technical solutions, ensuring that your shipments will always be treated as unique and urgent while also recognizing that they are highly valuable.

Sectors we support

API's and Commercial Drugs

CRYOPDP partners with some of the world’s leading API manufacturers and also leading commercial drug organizations within key global areas from pharmerging regions such as India and China to key EU and US commercial distribution markets.

It is the rapid flexibility approach of our teams to key bulk moves that helps to develop key global client-partner strategic alliances.

Biological samples

Correct packing and shipping of biological substances is fundamental to preventing potential exposure to infectious diseases that may affect people and animals.

At CRYOPDP, our teams focus on distinguishing the substance categories (A and B) of your drug products to ensure their efficacy and safe delivery. We ensure reliability and security for the entire cold chain during your shipment.

Cell & Gene Therapy

Our CRYODP global teams are acutely aware of the seismic shift in focusing on more ATMP and Cell & Gene Therapy drug development.

By working with our partners to present enhanced security options and a better focus on regulatory requirements while seeking to reduce cost models, CRYOPDP has developed global transport solutions that mitigate risks and deliver real-time supply chain tracking and visibility.

Let’s find the best solution together

Whatever your requirements, you can count on CRYOPDP thanks to it’s optimal control of cold technologies, its customized solutions and its dedicated teams. Contact us or ask for a free quote here.

Find your solution